Deciphera

Manufacturing · Massachusetts, United States · 201-500 Employees

View Company Info for Free

Overview

Headquarters

200 Smith St, Waltham, Massachusetts, 02...

Phone Number

(781) 209-6400

Website

www.deciphera.com

Revenue

$174.9 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Deciphera

Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera's FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Australia, Canada, China, and Hong Kong.Explore more
Deciphera's Social MediaSIC Code 28,283NAICS Code 32,325Show more

Deciphera Org Chart

RU
United States flag for contact location.
Ryota Udagawa

President & Chief Executive Officer

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
MH
United States flag for contact location.
Masahiro Hamada

Vice President, Chief of Staff

PhoneEmail
AL
United States flag for contact location.
Annah Litzenberger

Chief Human Resources Officer

PhoneEmail
MS
United States flag for contact location.
Matt Sherman

Chief Medical Officer

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email

PhoneEmail
Get the full picture
Sign in to uncover key details.
PH
United States flag for contact location.
Peter Habura

Senior VP, Quality & Pharmacovigilance

PhoneEmail
RS
United States flag for contact location.

Senior VP, Clinical Development

PhoneEmail
TB
United States flag for contact location.

Vice President, Commercial Insights & Operati...

PhoneEmail
FR
United States flag for contact location.

Vice President, Clinical Development

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
MS
United States flag for contact location.

Vice President, Clinical Development

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
SS
United States flag for contact location.

Vice President, Clinical Development

PhoneEmail
JS
United States flag for contact location.

Global Vice President, Supply Chain

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Deciphera

Compare insights from companies similar to Deciphera, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Deciphera

$174.9M
201-500
Private
$994.5M
2003
RU
Ryota UdagawaPresident & CEO
Exelixis
$2.4B
1K - 5K
Public
$118.3M
1994
CP
Craig PalmerSenior Vice President, Chief of Staff
Blueprint Medicines
$562.1M
501-1,000
Private
$2B
2008
DD
Debbie Durso-BumpusChief People Officer
ADMA Biologics
$512.3M
501-1,000
Public
$462.6M
2004
Terence Kohler, Chief Financial Officer & Treasurer at ADMA Biologics
Terence KohlerChief Financial Officer & Treasurer
Karyopharm Therapeutics
$151.1M
201-500
Public
$1.1B
2008
Richard Paulson, President & Chief Executive Officer at Karyopharm Therapeutics
Richard PaulsonPresident & CEO
Enanta Pharmaceuticals
$69.2M
51-200
Public
$191M
1995
Matthew Kowalsky, Chief Legal Officer at Enanta Pharmaceuticals
Matthew KowalskyChief Legal Officer
Revolution Medicines
501-1,000
Public
$579.9M
2014
Walter Reiher, Chief Information Officer at Revolution Medicines
Walter ReiherChief Information Officer
Illustration of an envelope

Deciphera Tech Stack

A closer look at the technologies used by Deciphera

DocuSign

By

DocuSign
WordPress.org

By

Automattic
Drupal

By

Drupal
iCIMS

By

iCIMS
See more technologies

Top Manufacturing Companies

Top companies in Canada by revenue

Bausch Health
Marcan Pharmaceuticals
AgMedica Bioscience
Euro-Pharm International Canada
IKARIA Canada
View Full List

Top companies in Australia by revenue

Activ Australia
Johnson & Johnson Pacific
Cymra Life Sciences
Palla Pharma
Immuron
View Full List

Top companies in New Zealand by revenue

TRG Natural Pharmaceuticals
AFT Pharmaceuticals
Douglas Pharmaceuticals
Rua Bioscience
Health Source NZ
View Full List
See more top companies

Frequently Asked Questions Regarding Deciphera

What is Deciphera's official website?
Deciphera's official website is www.deciphera.com What is Deciphera's Revenue?
Deciphera's revenue is $174.9 Million What is Deciphera's SIC code?
Deciphera's SIC: 28,283 What is Deciphera's NAICS code?
Deciphera's NAICS: 32,325 How many employees does Deciphera have?
Deciphera has 201-500 employees What industry does Deciphera belong to?
Deciphera is in the industry of: Manufacturing, Pharmaceuticals, Business Services What is Deciphera competition?
Deciphera top competitors include: Exelixis, Enanta Pharmaceuticals, Blueprint Medicines, Karyopharm Therapeutics What companies has Deciphera acquired?
Deciphera has acquired the companies: Deciphera What technology does Deciphera use?
Some of the popular technologies that Deciphera uses are: DocuSign, WordPress.org, Drupal, iCIMS How do I contact Deciphera?
Deciphera contact info: Phone number: (781) 209-6400 Website: www.deciphera.com What does Deciphera do?

Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advan... cing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera's FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Australia, Canada, China, and Hong Kong.Read More

 What are Deciphera social media links?
Deciphera Linkedin page Deciphera Twitter page Deciphera Facebook page Who invested in Deciphera?
Deciphera has 10 investors including Viking Global Investors, New Leaf Venture Partners, SV Life Sciences and New Leaf Venture Partners. Is Deciphera a public company?
Deciphera is private company therefore does not currently have an official ticker symbol
See more information about Deciphera

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.

Test Drive ZoomInfo's Directories

Browse Directories

Most Searched Industries

Construction Law Firms & Legal Services Business Services Finance Manufacturing Agriculture Software Accounting & Accounting Services Retail Healthcare Energy, Utilities & Waste Treatment Telecommunications Transportation Real Estate
People SearchCompany Search